Physician

David M Chacko, M.D., PH.D.

According to 2025 Medicare claims, David Chacko, M.D., PH.D. (NPI: 1922167303) practices ophthalmology in the Wichita, KS market, with the plurality of this provider's patient population coming from Sedgwick, KS. This provider's primary affiliated billing organization is GRENE VISION GROUP LLC (NPI: 1285627562; TIN: 481174116) and primary practice location at 67206-3513.

Chacko's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,644 traditional Medicare patients, billed 32,080 HCPCS/CPT codes, and received $2,529,443 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 2,817 prescription claims across 915 beneficiaries totaling $158,226 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 11 records totaling $238. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $82,571 to $158,226. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,120	40,926	$1,792,092
2016	2,171	36,574	$2,002,091
2017	2,050	34,397	$1,514,277
2018	2,079	32,257	$1,317,216
2019	2,107	32,176	$1,211,276
2020	1,850	23,653	$1,111,737
2021	1,972	23,750	$1,369,990
2022	1,890	14,916	$1,403,977
2023	1,776	19,551	$2,087,266
2024	1,644	32,080	$2,529,443

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	681	1,947	$82,571
2016	721	1,992	$75,010
2017	729	2,115	$73,952
2018	774	2,384	$79,600
2019	769	2,724	$94,081
2020	772	2,981	$85,194
2021	819	2,904	$93,537
2022	816	2,821	$89,083
2023	790	2,687	$84,682
2024	915	2,817	$158,226

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	746	2,817	$85
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	669	692	$82
J7999	Compounded drug, not otherwise classified	574	2,147	$38
92134	Imaging of retina	1,093	2,446	$26
92250	Photography of the retina	638	1,251	$22

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	371	11,388	$14,771
Xiidra	Lifitegrast	15	450	$10,473
Brimonidine Tartrate	Brimonidine Tartrate	337	13,615	$5,039
Polymyxin B Sul-Trimethoprim	Polymyxin B Sulf/Trimethoprim	610	19,629	$4,180
Latanoprost	Latanoprost	555	27,983	$3,813

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$238	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David M. Chacko, M.D., PH.D.?

Tedicare shows public-source Medicare data for David M. Chacko, M.D., PH.D. (NPI 1922167303), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David M. Chacko, M.D., PH.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David M. Chacko, M.D., PH.D.?

David M. Chacko, M.D., PH.D. is linked to GRENE VISION GROUP LLC (billing NPI 1285627562) in the available physician profile data.

Does David M. Chacko, M.D., PH.D. have Open Payments data?

David M. Chacko, M.D., PH.D. has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.